Acellular pertussis vaccines: where to go to?

Affiliations

Comment

Carl Heinz Wirsing von König. Lancet Infect Dis. 2018 Jan.

. 2018 Jan;18(1):5-6.

doi: 10.1016/S1473-3099(17)30613-8. Epub 2017 Oct 20.

¹ Labor:Medizin Krefeld MVZ, Krefeld 47805, Germany. Electronic address: chwvk@gmx.de.

No abstract available

Comment on

A genetically inactivated two-component acellular pertussis vaccine, alone or combined with tetanus and reduced-dose diphtheria vaccines, in adolescents: a phase 2/3, randomised controlled non-inferiority trial.
Sricharoenchai S, Sirivichayakul C, Chokephaibulkit K, Pitisuttithum P, Dhitavat J, Pitisuthitham A, Phongsamart W, Boonnak K, Lapphra K, Sabmee Y, Wittawatmongkol O, Chinwangso P, Poredi IK, Petre J, Thai PH, Viviani S. Sricharoenchai S, et al. Lancet Infect Dis. 2018 Jan;18(1):58-67. doi: 10.1016/S1473-3099(17)30612-6. Epub 2017 Oct 20. Lancet Infect Dis. 2018. PMID: 29066131 Clinical Trial.